While the White House and doctors at Walter Reed have sought to reassure the public that Trump's condition is improving, he has received numerous drugs for Covid-19, including the steroid dexamethasone, which is typically administered only to those who are critically ill.
The agency's Covid-19 Treatment Guidelines Panel stated there was insufficient evidence for or against the treatment and pointed out that in certain groups, such as intubated patients, no benefit in seven-day overall survival was observed.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The NIAID create the Covid-19 Prevention Trials Network by combining four existing ones, primarily focused on HIV and AIDS, which will continue that work in addition to their new focus on Covid-19.
Science magazine reported that the move put the brakes on a preclinical HIV study and follows the cancellation of a contract between the FDA and a California-based company that supplies fetal tissue for medical research.
The two companies are working to develop an integrated product called GetWell Loop, in the latest example of consolidation in the patient engagement industry.
Bethesda, Maryland-based RightEye has received a 510(k) clearance for its EyeQ eye-tracking platform using competitor SyncThink's technology as a predicate device.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
At CES, Bethesda, Maryland-based RightEye unveiled its new EyeQ system. The startup's EyeQ vision tests measure and analyze people's eye movements.
Through the new collaboration, which was announced during this year's AMIA Annual Symposium, OpenNotes and the American Medical Informatics Association want to give patients better access to their provider's clinical notes.
AusculTech Dx is developing a device to help pediatricians recognize Still’s murmur, to reduce unnecessary referrals and the incredible stress.
Right now, Clinical Center leadership has little authority within NIH because clinicians and researchers in the hospital report to the heads of NIH's 27 different institutes and centers.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The profile of patient advocates has been building steadily, but they’re also facing some interesting questions about their identity as they figure out how to maximize their effectiveness. In a Patients Town Hall to recap some of the highlights of the ENGAGE conference this week, panelists talked about what they need to make patients more […]
The desire by patients to take control of their data combined with the growth of personalized medicine raises an interesting question? What’s the best way for doctors to give patients genetic test results? Readmission is also a vexing issue, particularly for COPD. What kind of insights could patients offer doctors to change how they provide […]
It used to be that patients would wait for the physician or the health system to engage them, but increasingly the patient is charting their own course, having grown tired of the slow-moving behemoth of our healthcare system and enabled by advances in technology that have been applied to other industries. Dr. Joseph Smith, chief […]
One of the biggest challenges that healthcare professionals face is figuring out the level of health literacy their patients possess so they can convey information in a way that’s understandable to them. If they don’t, there is the strong possibility that patients won’t follow medication and other instructions and their health won’t improve. It’s particularly […]